The national Centers for Disease Control and Prevention estimates that approximately 4 million men and women are infected by Chlamydia trachomatis and Neisseria gonorrhoeae every year, and up to 40 percent of untreated women develop Pelvic Inflammatory Disease (PID) as a complication.

Considering that up to 75% of women and 50% of men who have chlamydia and/or gonorrhea have no symptoms, routine screening and early, effective treatment are the keys to reducing the high prevalence of CT/GC and the incidence of PID.

BD has developed a new program to help create awareness amongt patients, to help physicians follow current recommendations, and to make the latest DNA amplification technology available.